Annual CFF
$113.81 M
+$90.81 M+394.70%
December 31, 2023
Summary
- As of February 7, 2025, BNGO annual cash flow from financing activities is $113.81 million, with the most recent change of +$90.81 million (+394.70%) on December 31, 2023.
- During the last 3 years, BNGO annual CFF has risen by +$51.91 million (+83.86%).
- BNGO annual CFF is now -66.14% below its all-time high of $336.11 million, reached on December 31, 2021.
Performance
BNGO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$6.02 M
+$8.00 M+404.40%
September 1, 2024
Summary
- As of February 7, 2025, BNGO quarterly cash flow from financing activities is $6.02 million, with the most recent change of +$8.00 million (+404.40%) on September 1, 2024.
- Over the past year, BNGO quarterly CFF has dropped by -$62.46 million (-91.21%).
- BNGO quarterly CFF is now -98.22% below its all-time high of $337.54 million, reached on March 31, 2021.
Performance
BNGO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$50.91 M
-$6.57 M-11.43%
September 1, 2024
Summary
- As of February 7, 2025, BNGO TTM cash flow from financing activities is $50.91 million, with the most recent change of -$6.57 million (-11.43%) on September 1, 2024.
- Over the past year, BNGO TTM CFF has dropped by -$62.91 million (-55.27%).
- BNGO TTM CFF is now -87.29% below its all-time high of $400.57 million, reached on March 31, 2021.
Performance
BNGO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BNGO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +394.7% | -91.2% | -55.3% |
| 3 y3 years | +83.9% | +10000.0% | +3690.2% |
| 5 y5 years | +218.1% | -63.0% | +50.4% |
BNGO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.1% | +394.7% | -91.2% | +127.8% | -84.8% | +3690.2% |
| 5 y | 5-year | -66.1% | +394.7% | -98.2% | +127.8% | -87.3% | +3690.2% |
| alltime | all time | -66.1% | +546.4% | -98.2% | +127.8% | -87.3% | +3690.2% |
Bionano Genomics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.02 M(-404.4%) | $50.91 M(-11.4%) |
| Jun 2024 | - | -$1.98 M(-90.9%) | $57.48 M(-25.7%) |
| Mar 2024 | - | -$21.62 M(-131.6%) | $77.33 M(-32.1%) |
| Dec 2023 | $113.81 M(+394.7%) | $68.48 M(+444.0%) | $113.81 M(+150.3%) |
| Sep 2023 | - | $12.59 M(-29.6%) | $45.48 M(-18.1%) |
| Jun 2023 | - | $17.88 M(+20.3%) | $55.54 M(+46.7%) |
| Mar 2023 | - | $14.86 M(>+9900.0%) | $37.86 M(+64.6%) |
| Dec 2022 | $23.01 M(-93.2%) | $146.00 K(-99.4%) | $23.01 M(-7.3%) |
| Sep 2022 | - | $22.65 M(>+9900.0%) | $24.83 M(+55.7%) |
| Jun 2022 | - | $203.00 K(+2800.0%) | $15.94 M(-1224.3%) |
| Mar 2022 | - | $7000.00(-99.6%) | -$1.42 M(-100.4%) |
| Dec 2021 | $336.11 M(+443.0%) | $1.97 M(-85.7%) | $336.11 M(-8.1%) |
| Sep 2021 | - | $13.77 M(-180.2%) | $365.83 M(-0.4%) |
| Jun 2021 | - | -$17.16 M(-105.1%) | $367.15 M(-8.3%) |
| Mar 2021 | - | $337.54 M(+965.3%) | $400.57 M(+547.1%) |
| Dec 2020 | $61.90 M | $31.69 M(+110.1%) | $61.90 M(+27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $15.08 M(-7.3%) | $48.71 M(+43.9%) |
| Jun 2020 | - | $16.27 M(-1533.3%) | $33.84 M(+84.1%) |
| Mar 2020 | - | -$1.14 M(-106.1%) | $18.39 M(-39.5%) |
| Dec 2019 | $30.38 M(-15.1%) | $18.49 M(+8382.3%) | $30.38 M(+156.2%) |
| Sep 2019 | - | $218.00 K(-73.1%) | $11.86 M(-61.6%) |
| Jun 2019 | - | $811.00 K(-92.5%) | $30.90 M(-7.2%) |
| Mar 2019 | - | $10.86 M(<-9900.0%) | $33.31 M(-6.9%) |
| Dec 2018 | $35.78 M(+103.2%) | -$32.30 K(-100.2%) | $35.78 M(-4.0%) |
| Sep 2018 | - | $19.26 M(+499.0%) | $37.28 M(+78.2%) |
| Jun 2018 | - | $3.22 M(-75.9%) | $20.92 M(-12.7%) |
| Mar 2018 | - | $13.33 M(+804.0%) | $23.96 M(+36.1%) |
| Dec 2017 | $17.61 M(-30.8%) | $1.47 M(-49.2%) | $17.61 M(+9.1%) |
| Sep 2017 | - | $2.90 M(-53.6%) | $16.13 M(+21.9%) |
| Jun 2017 | - | $6.26 M(-10.3%) | $13.23 M(+89.7%) |
| Mar 2017 | - | $6.98 M | $6.98 M |
| Dec 2016 | $25.43 M | - | - |
FAQ
- What is Bionano Genomics annual cash flow from financing activities?
- What is the all time high annual CFF for Bionano Genomics?
- What is Bionano Genomics annual CFF year-on-year change?
- What is Bionano Genomics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bionano Genomics?
- What is Bionano Genomics quarterly CFF year-on-year change?
- What is Bionano Genomics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bionano Genomics?
- What is Bionano Genomics TTM CFF year-on-year change?
What is Bionano Genomics annual cash flow from financing activities?
The current annual CFF of BNGO is $113.81 M
What is the all time high annual CFF for Bionano Genomics?
Bionano Genomics all-time high annual cash flow from financing activities is $336.11 M
What is Bionano Genomics annual CFF year-on-year change?
Over the past year, BNGO annual cash flow from financing activities has changed by +$90.81 M (+394.70%)
What is Bionano Genomics quarterly cash flow from financing activities?
The current quarterly CFF of BNGO is $6.02 M
What is the all time high quarterly CFF for Bionano Genomics?
Bionano Genomics all-time high quarterly cash flow from financing activities is $337.54 M
What is Bionano Genomics quarterly CFF year-on-year change?
Over the past year, BNGO quarterly cash flow from financing activities has changed by -$62.46 M (-91.21%)
What is Bionano Genomics TTM cash flow from financing activities?
The current TTM CFF of BNGO is $50.91 M
What is the all time high TTM CFF for Bionano Genomics?
Bionano Genomics all-time high TTM cash flow from financing activities is $400.57 M
What is Bionano Genomics TTM CFF year-on-year change?
Over the past year, BNGO TTM cash flow from financing activities has changed by -$62.91 M (-55.27%)